Texas Accountant Allegedly Embezzles 3 Million From Employer Funding Luxury Lifestyle Amazon Reports BestEver Thanksgiving Holiday Week Sales and Item Volume Tesla Expands Full SelfDriving Supervised to China as Domestic EV Rivals Accelerate Autonomous Tech Gossamer Bio Investors Urged to Act Before Securities Class Action Deadline Rosen Law Firm Oil Price Reversal Highlights Geopolitical Risk as Key Driver for Crude Markets Prediction Market Investments Remain Robust Despite Regulatory Uncertainty Earnings Calls Reveal Indaptus Therapeutics Inc INDP Q4 2025 Earnings Deeper Loss Yet Shares Surge on Pipeline Progress ResMed Inc RMD Q1 2026 Earnings EPS Beat Driven by Strong Operating Leverage Stock Edges Lower PZG Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Phase BJDX Q4 2023 Earnings EPS Falls Far Below Estimates Revenue Remains Absent Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Parsons Corporation PSN Q1 2026 Earnings EPS Surges Past Estimates as Operational Execution Drives Performance FST Corp KBSX Slips 22 as Support at 128 Comes Into Focus Critical Metals Corp Faces Resistance Near 12 as Shares Edge Lower but Support Holds at 11 BioRad Laboratories BIO Gains 2 as Shares Approach Key Resistance Level United Maritime Corporation USEA Surges 424 Testing Key Resistance After Support Bounce Microvast Holdings MVST Shows Resilience Climbing 58 to 146 Quince Therapeutics QNCX Jumps 9 Testing Key Resistance at 126 BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Higher as Income Demand Persists Seaport Entertainment Group SEG Rebounds Key Levels to Watch After 272 Gain Lifetime Brands LCUT Faces Modest Pressure Testing Key Support Levels Western Asset Investment Grade Opportunity Trust IGI Holds Steady Near Key Support Resistance Ahead Cohen Circle Acquisition Corp II Warrants CCIIW Hold Steady at 075 Amid Quiet Trading Spencer Pratts Digital Strategy Redefining Political Campaigns for the Online Era Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher PROCEPT BioRobotics PRCT Slips 36 as Selling Pressure Tests Key Support